Results
Camlin Fine Sciences Q2 FY27 Results & INR250cr Rights Issue
Camlin Fine Sciences reported weak Q2 FY27 results with consolidated EBITDA margin falling to 2.5% due to liquidity constraints and high raw material costs.
The Board approved a INR250 crore rights is